{"transactions":[{"id":4636457,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Restated Warrant (right to buy)","published_at":"2026-10-06T22:11:53.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":458,"price":1.5,"value":687.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement, issued in connection with the assumption of a portion of an assigned commitment pursuant to the Amendment.  The Reporting Person also holds a previously-reported separate Prepayment Restated Warrant that was issued on May 29, 2026, subject to the same vesting provision set forth in footnote (3) immediately below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vesting (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2027, in accordance with the Loan Agreement."}],"balance_after":458,"derivative":{"exercise_price":1.5,"exercise_date":"2026-10-06","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":458},"source":{"system":"sec-edgar","filing":"0001437749-26-032249","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674752/000143774926032249/rdgdoc.xml","form_type":"4"}},{"id":4636456,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Restated Warrant (right to buy)","published_at":"2026-10-06T22:11:53.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":1.5,"value":6750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Commitment, Origination Restated Second, and Capital Restate Second Warrants issued in connection with the assumption of a portion of an assigned funding commitment pursuant to the Assignment, Joinder, and Amendment No. 1 dated October 6, 2026 among the Issuer, the Reporting Person, and the other parties thereto (the \"Amendment\"), relating to the Amended and Restated Loan and Security Agreement dated May 29, 2026 (the \"Loan Agreement\").  The Reporting Person also holds a previously reported separate Second Restated Warrant that was issued and become exercisable on May 29, 2026."}],"balance_after":4500,"derivative":{"exercise_price":1.5,"exercise_date":"2026-10-06","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001437749-26-032249","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674752/000143774926032249/rdgdoc.xml","form_type":"4"}},{"id":672265,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-08-31T14:29:08.000Z","date":"2026-08-28","kind":"purchase","planned":false,"acquired":true,"shares":7984,"price":1.089,"value":8694.576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate transaction with the range set forth herein."}],"balance_after":2070000,"source":{"system":"sec-edgar","filing":"0001437749-26-029257","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926029257/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-29"}},{"id":672264,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-08-31T14:29:08.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":789,"price":1.07,"value":844.23,"ownership":{"direct":true},"balance_after":2062016,"source":{"system":"sec-edgar","filing":"0001437749-26-029257","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926029257/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-08-29"}},{"id":673283,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-08-29T01:46:35.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":7984,"price":1.089,"value":8694.576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate transaction with the range set forth herein."}],"balance_after":2070000,"source":{"system":"sec-edgar","filing":"0001437749-26-029236","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926029236/rdgdoc.xml","form_type":"4"}},{"id":673282,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-08-29T01:46:35.000Z","date":"2026-08-27","kind":"grant","planned":false,"acquired":true,"shares":789,"price":1.07,"value":844.23,"ownership":{"direct":true},"balance_after":2062016,"source":{"system":"sec-edgar","filing":"0001437749-26-029236","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926029236/rdgdoc.xml","form_type":"4"}},{"id":719171,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:31:19.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the options are exercisable as of June 30, 2027 and the balance vest quarterly over the subsequent two years."}],"balance_after":65000,"derivative":{"exercise_price":1.01,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001437749-26-022670","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022670/rdgdoc.xml","form_type":"4"}},{"id":719169,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:02:37.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the options are exercisable as of June 30, 2027 and the balance vest quarterly over the subsequent two years."}],"balance_after":125000,"derivative":{"exercise_price":1.01,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-26-022665","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022665/rdgdoc.xml","form_type":"4"}},{"id":719168,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:02:37.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":162500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"62,500 options exercisable on 07/01/2016, 50,000 options exercisable on 03/31/2017, and 50,000 options exercisable on 12/31/2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-12-31","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":162500},"source":{"system":"sec-edgar","filing":"0001437749-26-022665","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022665/rdgdoc.xml","form_type":"4"}},{"id":719167,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-07-03T01:02:37.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":160892,"price":1.01,"value":162500.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options. The reporting person received 1,608 shares of common stock on the net exercise of option to purchase 162,500 shares of common stock. The issuer withheld 160,892 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects an adjustment of 25,381 shares since the Reporting Person's most recent Form 4 filed June 5, 2026 to correct the amount of securities beneficially owned as a result of the transaction reported in that Form 4."}],"balance_after":2061227,"source":{"system":"sec-edgar","filing":"0001437749-26-022665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022665/rdgdoc.xml","form_type":"4"}},{"id":719166,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-07-03T01:02:37.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":162500,"price":1,"value":162500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects an adjustment of 25,381 shares since the Reporting Person's most recent Form 4 filed June 5, 2026 to correct the amount of securities beneficially owned as a result of the transaction reported in that Form 4."}],"balance_after":2222119,"source":{"system":"sec-edgar","filing":"0001437749-26-022665","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022665/rdgdoc.xml","form_type":"4"}},{"id":719165,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719164,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-01-01","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719163,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":39604,"price":1.01,"value":40000.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock.  The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01."}],"balance_after":5400396,"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719162,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2026-07-03T01:00:41.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":1,"value":40000.0,"ownership":{"direct":true},"balance_after":5440000,"source":{"system":"sec-edgar","filing":"0001437749-26-022664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022664/rdgdoc.xml","form_type":"4"}},{"id":719161,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719160,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2017-01-01","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719159,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":39604,"price":1.01,"value":40000.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock.  The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01."}],"balance_after":173050,"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719158,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-03T00:59:39.000Z","date":"2026-06-30","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":1,"value":40000.0,"ownership":{"direct":true},"balance_after":212654,"source":{"system":"sec-edgar","filing":"0001437749-26-022662","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022662/rdgdoc.xml","form_type":"4"}},{"id":719157,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2026-07-03T00:58:39.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest as of June 30, 2027."}],"balance_after":30000,"derivative":{"exercise_price":1.01,"exercise_date":"2027-06-30","expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-022661","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926022661/rdgdoc.xml","form_type":"4"}},{"id":748624,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-06-05T22:34:26.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":13245,"price":1.0952,"value":14505.924,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.042 to $1.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate transaction with the range set forth herein."}],"balance_after":2085000,"source":{"system":"sec-edgar","filing":"0001437749-26-019768","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019768/rdgdoc.xml","form_type":"4"}},{"id":755769,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Restated Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":7333,"price":1.5,"value":10999.5,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F5","text":"Previously issued Prepayment Warrants cancelled for Prepayment Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Loan Agreement."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Vesting (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-05-29","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755768,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Restated Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":1.5,"value":26250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F4","text":"Previously issued Second Warrants cancelled for Second Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Amended and Restated Loan and Security Agreement dated May 29, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vesting (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755767,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F5","text":"Previously issued Prepayment Warrants cancelled for Prepayment Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755766,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36750,"price":1.5,"value":55125.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents Origination Restated Second and Capital Restated Second Warrants."},{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"},{"field":"kind","element":"transactionCoding","label":"F4","text":"Previously issued Second Warrants cancelled for Second Restated Warrants with same terms, including same exercise price (and cancelled on date when underlying Common Stock traded at lower price than when previously issued), in accordance with the Amended and Restated Loan and Security Agreement dated May 29, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755765,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Interim Warrant (right to buy)","published_at":"2026-06-03T01:54:30.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":17450,"price":1.5,"value":26175.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Origination Interim and Capital Interim Warrants."},{"field":"date","element":"transactionDate","label":"F2","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":17450,"derivative":{"exercise_price":1.5,"exercise_date":"2026-05-29","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":17450},"source":{"system":"sec-edgar","filing":"0001437749-26-019246","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019246/rdgdoc.xml","form_type":"4"}},{"id":755763,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":755762,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Second Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":36750,"price":1.5,"value":55125.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Second Warrant, which represents Origination Second Capital Second Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":755761,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Initial Warrant (right to buy)","published_at":"2026-06-03T01:49:53.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":30050,"price":1.5,"value":45075.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 amendment corrects the name of warrant issued in the form of an integrated Initial Warrant, which represents Commitment Initial, Origination Initial, and Capital Initial Warrants immediately exercisable for an aggregate of 30,050 shares of Common Stock."}],"balance_after":30050,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":30050},"source":{"system":"sec-edgar","filing":"0001437749-26-019244","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926019244/rdgdoc.xml","form_type":"4/A","original_submission_date":"2026-01-26"}},{"id":931389,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Prepayment Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":7516,"price":1.5,"value":11274.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will vest (if at all) upon the occurrence of a Prepayment, but no later than December 31, 2028, in accordance with the Loan Agreement."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Represents maximum number of shares issuable (if at all) in the event of a Prepayment in accordance with the Loan Agreement.\n\n\nThe Board of Directors of Issuer and Non-Employee Directors approved the Loan Agreement and issuance of warrants and shares of Common Stock issuable thereunder"}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":7516},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931388,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Capital Second Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":1.5,"value":52500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931387,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Origination Second Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":1750,"price":1.5,"value":2625.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest (if at all) on September 30, 2026 provided a Second Funding occurs in accordance with the Loan and Security Agreement dated January 21, 2026 among the Issuer, the Reporting Person, and other parties thereto (the \"Loan Agreement\")."}],"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-09-30","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931386,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Capital Initial Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":26667,"price":1.5,"value":40000.5,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931385,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Origination Initial Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":1.5,"value":1999.5,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":931384,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Commitment Warrants (right to buy)","published_at":"2026-01-26T23:44:05.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":2050,"price":1.5,"value":3075.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.5,"exercise_date":"2026-01-23","expiration_date":"2031-01-23","underlying":"Common Stock","underlying_shares":2050},"source":{"system":"sec-edgar","filing":"0001437749-26-002128","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926002128/rdgdoc.xml","form_type":"4"}},{"id":953102,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T00:25:34.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001437749-26-000431","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926000431/rdgdoc.xml","form_type":"4"}},{"id":953101,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-01-06T00:25:34.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":25381,"price":1.97,"value":50000.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options. The reporting person received 99,619 shares of common stock on the net exercise of option to purchase 125,000 shares of common stock. The issuer withheld 25,381 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.97."}],"balance_after":2046374,"source":{"system":"sec-edgar","filing":"0001437749-26-000431","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926000431/rdgdoc.xml","form_type":"4"}},{"id":953100,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2026-01-06T00:25:34.000Z","date":"2026-01-01","kind":"exercise","planned":false,"acquired":true,"shares":125000,"price":0.4,"value":50000.0,"ownership":{"direct":true},"balance_after":2071755,"source":{"system":"sec-edgar","filing":"0001437749-26-000431","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926000431/rdgdoc.xml","form_type":"4"}},{"id":961428,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-31","kind":"exercise","planned":false,"acquired":false,"shares":68750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":68750},"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":961427,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":13750,"price":2,"value":27500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 55,000 shares of common stock on the net exercise of option to purchase 68,750 shares of common stock.  The issuer withheld 13,750 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.00."}],"balance_after":172654,"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":961426,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-22T16:53:25.000Z","date":"2025-12-17","kind":"exercise","planned":false,"acquired":true,"shares":68750,"price":0.4,"value":27500.0,"ownership":{"direct":true},"balance_after":186404,"source":{"system":"sec-edgar","filing":"0001437749-25-038506","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925038506/rdgdoc.xml","form_type":"4"}},{"id":973146,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-12T02:55:15.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973145,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-12T02:55:15.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9091,"price":2.2,"value":20000.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock.  The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20."}],"balance_after":108294,"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973144,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-12T02:55:15.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":117385,"source":{"system":"sec-edgar","filing":"0001437749-25-037614","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037614/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-12-11"}},{"id":973143,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-12-11T23:51:43.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":973142,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-11T23:51:43.000Z","date":"2025-12-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":9091,"price":2.2,"value":20000.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 40,909 shares of common stock on the net exercise of option to purchase 50,000 shares of common stock.  The issuer withheld 9,091 shares of common stock underlying the option for payment of the exercise price using the closing price of $2.20."}],"balance_after":108294,"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":973141,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-11T23:51:43.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.4,"value":20000.0,"ownership":{"direct":true},"balance_after":117385,"source":{"system":"sec-edgar","filing":"0001437749-25-037591","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925037591/rdgdoc.xml","form_type":"4"}},{"id":982418,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2025-12-03T23:13:16.000Z","date":"2025-11-28","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":1.5,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein was made in a private transaction to facilitate a personal real estate transaction whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":1946755,"source":{"system":"sec-edgar","filing":"0001437749-25-036821","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925036821/rdgdoc.xml","form_type":"4"}},{"id":1076666,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:36:44.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":120313,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":120313},"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076665,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:36:44.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":27659,"price":1.74,"value":48126.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 92,654 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":117654,"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076664,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:36:44.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120313,"price":0.4,"value":48125.2,"ownership":{"direct":true},"balance_after":145313,"source":{"system":"sec-edgar","filing":"0001437749-25-024508","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024508/rdgdoc.xml","form_type":"4/A","original_submission_date":"2025-08-04"}},{"id":1076662,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:26:56.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":120313,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":120313},"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1076661,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:26:56.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":27659,"price":1.74,"value":48126.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 90,606 shares of common stock on the net exercise of option to purchase 120,313 shares of common stock.  The issuer withheld 27,659 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":117654,"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1076660,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:26:56.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":120313,"price":0.4,"value":48125.2,"ownership":{"direct":true},"balance_after":145313,"source":{"system":"sec-edgar","filing":"0001437749-25-024505","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024505/rdgdoc.xml","form_type":"4"}},{"id":1076659,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:13:40.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1076658,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:13:40.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":20115,"price":1.74,"value":35000.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options.  The reporting person received 67,385 shares of common stock on the net exercise of option to purchase 87,500 shares of common stock.  The issuer withheld 20,115 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":67385,"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1076657,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-04T13:13:40.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":87500,"price":0.4,"value":35000.0,"ownership":{"direct":true},"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001437749-25-024499","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024499/rdgdoc.xml","form_type":"4"}},{"id":1076654,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:09:44.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":192710,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":192710},"source":{"system":"sec-edgar","filing":"0001437749-25-024497","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024497/rdgdoc.xml","form_type":"4"}},{"id":1076653,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2025-08-04T13:09:44.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":21313,"price":1.74,"value":37084.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a net exercise of outstanding stock options. The reporting person received 71,397 shares of common stock on the net exercise of option to purchase 92,710 shares of common stock. The issuer withheld 21,313 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.74."}],"balance_after":2146755,"source":{"system":"sec-edgar","filing":"0001437749-25-024497","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024497/rdgdoc.xml","form_type":"4"}},{"id":1076652,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2025-08-04T13:09:44.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":92710,"price":0.4,"value":37084.0,"ownership":{"direct":true},"balance_after":2168068,"source":{"system":"sec-edgar","filing":"0001437749-25-024497","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024497/rdgdoc.xml","form_type":"4"}},{"id":1076651,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2025-08-04T13:09:44.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0.4,"value":40000.0,"ownership":{"direct":true},"balance_after":2075358,"source":{"system":"sec-edgar","filing":"0001437749-25-024497","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024497/rdgdoc.xml","form_type":"4"}},{"id":1076656,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Option to purchase common stock","published_at":"2025-08-04T13:06:50.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":183853,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-08","underlying":"Common Stock","underlying_shares":183853},"source":{"system":"sec-edgar","filing":"0001437749-25-024493","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024493/rdgdoc.xml","form_type":"4"}},{"id":1076655,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Common Stock","published_at":"2025-08-04T13:06:50.000Z","date":"2025-07-31","kind":"exercise","planned":false,"acquired":true,"shares":183853,"price":0.4,"value":73541.2,"ownership":{"direct":true},"balance_after":770054,"source":{"system":"sec-edgar","filing":"0001437749-25-024493","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024493/rdgdoc.xml","form_type":"4"}},{"id":1077845,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-08-01T22:07:43.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":3946,"price":1.5,"value":5919.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5400000,"source":{"system":"sec-edgar","filing":"0001437749-25-024429","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774925024429/rdgdoc.xml","form_type":"4"}},{"id":1077857,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2025-08-01T18:03:29.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":1.5,"value":199999.5,"ownership":{"direct":true},"balance_after":11570833,"source":{"system":"sec-edgar","filing":"0001437749-25-024427","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774925024427/rdgdoc.xml","form_type":"4"}},{"id":1360085,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2022-03-04","kind":"exercise","planned":false,"acquired":false,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360084,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2018-12-31","kind":"exercise","planned":false,"acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360083,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2018-08-09","kind":"exercise","planned":false,"acquired":false,"shares":121875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-09","underlying":"Common Stock","underlying_shares":121875},"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360082,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":33334,"price":0.5,"value":16667.0,"ownership":{"direct":true},"balance_after":5396054,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360081,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"balance_after":5362720,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1360080,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-11-19T22:51:41.000Z","date":"2024-11-15","kind":"exercise","planned":false,"acquired":true,"shares":121875,"price":0.4,"value":48750.0,"ownership":{"direct":true},"balance_after":5300220,"source":{"system":"sec-edgar","filing":"0001437749-24-035771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924035771/rdgdoc.xml","form_type":"4"}},{"id":1402769,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-09-19T20:21:45.000Z","date":"2024-09-18","kind":"purchase","planned":false,"acquired":true,"shares":125000,"price":0.75,"value":93750.0,"ownership":{"direct":true},"balance_after":11437500,"source":{"system":"sec-edgar","filing":"0001437749-24-029634","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774924029634/rdgdoc.xml","form_type":"4"}},{"id":1450698,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33213,"kind":"person","name":"WINZER C ERIC","position":1,"cik":"0001205362","reported_name":"WINZER C ERIC","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:58:42.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0.33,"value":13200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-24-023228","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023228/rdgdoc.xml","form_type":"4"}},{"id":1450697,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:55:22.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0.33,"value":13200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-24-023226","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023226/rdgdoc.xml","form_type":"4"}},{"id":1450696,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-07-22T22:50:53.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0.33,"value":8250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vest on one year anniversary of grant."}],"balance_after":25000,"derivative":{"exercise_price":0.33,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-24-023224","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924023224/rdgdoc.xml","form_type":"4"}},{"id":1507611,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Common Stock","published_at":"2024-05-21T19:13:21.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0.75,"value":11250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":586201,"source":{"system":"sec-edgar","filing":"0001437749-24-017814","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924017814/rdgdoc.xml","form_type":"4"}},{"id":1507609,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-21T19:11:55.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0.75,"value":101250.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5178345,"source":{"system":"sec-edgar","filing":"0001437749-24-017813","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774924017813/rdgdoc.xml","form_type":"4"}},{"id":1507668,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2024-05-21T15:14:11.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.75,"value":75000.0,"ownership":{"direct":true},"balance_after":11312500,"source":{"system":"sec-edgar","filing":"0001437749-24-017815","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774924017815/rdgdoc.xml","form_type":"4"}},{"id":1703668,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Common Stock","published_at":"2023-12-20T19:04:23.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0.5,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":571201,"source":{"system":"sec-edgar","filing":"0001437749-23-034982","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923034982/rdgdoc.xml","form_type":"4"}},{"id":1703659,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-20T19:03:10.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0.5,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":5043345,"source":{"system":"sec-edgar","filing":"0001437749-23-034980","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923034980/rdgdoc.xml","form_type":"4"}},{"id":1703680,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-12-20T14:05:32.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":0.5,"value":75000.0,"ownership":{"direct":true},"balance_after":11212500,"source":{"system":"sec-edgar","filing":"0001437749-23-034984","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774923034984/rdgdoc.xml","form_type":"4"}},{"id":1815267,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-04T13:41:20.000Z","date":"2023-08-01","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":2,"value":125000.0,"ownership":{"direct":true},"balance_after":11062500,"source":{"system":"sec-edgar","filing":"0001437749-23-022109","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774923022109/rdgdoc.xml","form_type":"4"}},{"id":1816937,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Common Stock","published_at":"2023-08-03T20:18:21.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":551201,"source":{"system":"sec-edgar","filing":"0001437749-23-021950","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923021950/rdgdoc.xml","form_type":"4"}},{"id":1816936,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-08-03T20:17:11.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":2,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":4443345,"source":{"system":"sec-edgar","filing":"0001437749-23-021946","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774923021946/rdgdoc.xml","form_type":"4"}},{"id":2118695,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":5000,"price":1.5,"value":7500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":1975358,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118694,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":7000,"price":1.5,"value":10500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":1980358,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118693,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":10000,"price":1.5,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":1987358,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118692,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":13500,"price":1.5,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":1997358,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118691,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":20000,"price":1.5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":2010858,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118690,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":20000,"price":1.5,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":2030858,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118689,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":27000,"price":1.5,"value":40500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":2050858,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118688,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":30000,"price":1.5,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":2077858,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2118687,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-11-14T23:43:28.000Z","date":"2022-11-09","kind":"sale","acquired":false,"shares":30000,"price":1.5,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute \"restricted\" securities within the meaning of the Securities Act of 1933, as amended."}],"balance_after":2107858,"source":{"system":"sec-edgar","filing":"0001437749-22-027386","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922027386/rdgdoc.xml","form_type":"4"}},{"id":2231816,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-06-15T22:18:32.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant of these options was approved by the issuer's Board of Directors on March 4, 2022, subject to stockholder approval of an amendment to increase the number of shares available for issuance under the issuer's 2016 Omnibus Incentive Compensation Plan pursuant to which the options were granted.  Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on April 27, 2022.  The stockholder approval became effective on June 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third exercisable immediately on 03/04/2022 and the remainder exercisable quarterly over three years."}],"balance_after":275000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001437749-22-015095","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922015095/rdgdoc.xml","form_type":"4"}},{"id":2286888,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":18479,"kind":"person","name":"JORDEN DAVID EMERSON","position":1,"cik":"0001313516","reported_name":"JORDEN DAVID EMERSON","relationship":{"director":true,"officer":true,"officer_title":"CEO/CFO"}}],"security":"Common Stock","published_at":"2022-05-02T16:23:53.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":10532,"price":1,"value":10532.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":2137858,"source":{"system":"sec-edgar","filing":"0001437749-22-010382","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922010382/rdgdoc.xml","form_type":"4"}},{"id":2286887,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33216,"kind":"person","name":"CLAUSEN PETER","position":1,"cik":"0001605411","reported_name":"CLAUSEN PETER","relationship":{"officer":true,"officer_title":"CSO/COO"}}],"security":"Common Stock","published_at":"2022-05-02T16:23:08.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":526201,"source":{"system":"sec-edgar","filing":"0001437749-22-010381","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922010381/rdgdoc.xml","form_type":"4"}},{"id":2286886,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33214,"kind":"person","name":"Pittman Scott M.","position":1,"cik":"0001674752","reported_name":"Pittman Scott M.","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-05-02T16:22:16.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Transaction approved by Board of Directors of Issuer and Non-Employee Directors"}],"balance_after":4343345,"source":{"system":"sec-edgar","filing":"0001437749-22-010379","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922010379/rdgdoc.xml","form_type":"4"}},{"id":2286924,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":77022,"kind":"person","name":"SHEEDY CHARLES E","position":1,"cik":"0001005483","reported_name":"SHEEDY CHARLES E","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2022-05-02T12:21:08.000Z","date":"2022-04-29","kind":"purchase","acquired":true,"shares":804868,"price":1,"value":804868.0,"ownership":{"direct":true},"balance_after":11000000,"source":{"system":"sec-edgar","filing":"0001437749-22-010378","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005483/000143774922010378/rdgdoc.xml","form_type":"4"}},{"id":2290524,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:35:22.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"derivative":{"exercise_price":0.75,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001437749-22-009790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009790/rdgdoc.xml","form_type":"4"}},{"id":2290523,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":33212,"kind":"person","name":"Mintz Paul","position":1,"cik":"0001480208","reported_name":"Mintz Paul","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2022-04-27T01:35:22.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":26666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019"}],"balance_after":26666,"derivative":{"exercise_price":0.5,"exercise_date":"2022-03-04","expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":26666},"source":{"system":"sec-edgar","filing":"0001437749-22-009790","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000143774922009790/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2022-04-27T01:35:22.000000Z,2290523"}